KESTRA MEDICAL TECHNOLOGIES, LTD.
KESTRA MEDICAL TECHNOLOGIES, LTD.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|
Share Based Compensation … | |||||||||||
West Affum Intermediate Holdings Corp | - | - | - | - | 0 | - | |||||
Assets | |||||||||||
Assets Current | |||||||||||
Cash And Cash Equivalents At Carrying Value | 100 | 291 | 175 | 201 | 238 | 54 | |||||
Receivable From Shareholders Or Affiliates For Iss… | - | - | - | - | - | -0 | |||||
Short Term Investments | 97 | - | - | - | - | - | |||||
Receivables Net Current | 15 | 13 | 10 | 9 | 8 | - | |||||
Prepaid Expense And Other Assets Current | 5 | 3 | 3 | 3 | 3 | - | |||||
Assets Current | 222 | 314 | 195 | 221 | 255 | - | |||||
Long Term Investments | 66 | - | - | - | - | - | |||||
Operating Lease Right Of Use Asset | 3 | 2 | 2 | 2 | 2 | - | |||||
Deposits Assets Noncurrent | 2 | 2 | 2 | 2 | 2 | - | |||||
Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | - | |||||
Property Plant And Equipment Net | 59 | 54 | 46 | 40 | 35 | - | |||||
Other Assets Noncurrent | 6 | 6 | 1 | 1 | 1 | - | |||||
Assets | 358 | 379 | 247 | 266 | 296 | - | |||||
Liabilities And Stockhold… | |||||||||||
Liabilities Current | |||||||||||
Accounts Payable Current | 27 | 24 | 20 | 19 | 24 | - | |||||
Accrued Liabilities Current | 23 | 19 | 15 | 14 | 14 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | - | |||||
Liabilities Current | 50 | 43 | 36 | 32 | 38 | - | |||||
Operating Lease Liability Noncurrent | 4 | 4 | 3 | 3 | 3 | - | |||||
Warrants And Rights Outstanding | 1 | 2 | 2 | 5 | 8 | - | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | - | |||||
Long Term Debt Noncurrent | 43 | 42 | 42 | 41 | 41 | - | |||||
Liabilities | 99 | 91 | 83 | 82 | 90 | - | |||||
Stockholders Equity Inclu… | |||||||||||
Common Stock Value | 58 | 58 | 51 | 51 | 51 | 0 | |||||
Additional Paid In Capital Common Stock | 853 | 843 | 691 | 679 | 674 | - | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -652 | -613 | -579 | -546 | -520 | - | |||||
Stockholders Equity | 260 | 288 | 164 | 184 | 205 | -258 | |||||
Liabilities And Stockholders Equity | 358 | 379 | 247 | 266 | 296 | - | |||||
Common Stock Par Or Stated Value Per Share | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Temporary Equity Shares Authorized | - | - | - | - | 0 | - | |||||
Temporary Equity Shares Issued | - | - | - | - | 0 | - | |||||
Common Stock Shares Issued | 58 | 58 | 51 | 51 | 51 | 100 | |||||
Temporary Equity Shares Outstanding | - | - | - | - | 0 | - | |||||
Shares Outstanding | 58 | 58 | 51 | 51 | 51 | 100 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 13.70% | 25.42% | 23.59% | -2.09% | -0.96% | -6.54% | -15.47% | -0.43% | -8.23% | 9.18% | - | - |
| 2025 | - | - | - | - | - | - | -7.45% | -15.51% | -36.04% | -11.79% | 3.28% | 50.79% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) — SEC Financial Statements & Analysis
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is a surgical & medical instruments & apparatus company, incorporated in D0. KESTRA MEDICAL TECHNOLOGIES, LTD. trades on Nasdaq as: KMTS. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), KESTRA MEDICAL TECHNOLOGIES, LTD. reported a Gross Profit Margin of 51.37% (TTM), a Debt-to-Equity ratio of 0.38x, a Price-to-Sales (P/S) ratio of 11.80x (TTM), a Price-to-Book (P/B) ratio of 4.32x (TTM), at a market cap of $1.12B. Figures below are sourced from SEC EDGAR, as-filed.
- Gross Profit Margin TTM
- 51.37%
- Debt To Equity
- 0.38x
- P/S TTM
- 11.80x
- P/B TTM
- 4.32x
- Market Cap
- $1.12B
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is KESTRA MEDICAL TECHNOLOGIES, LTD. in?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) operates in the Surgical & Medical Instruments & Apparatus industry.
What is KMTS's market cap?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) has a market capitalization of $1.12B as of 2026-04-30.
What exchange does KMTS trade on?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) trades on the Nasdaq.
Where is KESTRA MEDICAL TECHNOLOGIES, LTD. incorporated?
KESTRA MEDICAL TECHNOLOGIES, LTD. is incorporated in Bermuda.